- Home
- FOF vs FBRX Comparison
FOF vs FBRX Comparison
Compare FOF & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$26.83
Company Overview
Basic Information| Metric | FOF | FBRX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.4M | 379.3M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | FOF | FBRX |
|---|---|---|
| Price | $13.42 | $26.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 75.9K | ★ 172.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 9.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.97 | $4.91 |
| 52 Week High | $15.04 | $35.62 |
Technical Indicators
Market Signals| Indicator | FOF | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 39.92 |
| Support Level | $12.87 | $26.67 |
| Resistance Level | $14.50 | $32.40 |
| Average True Range (ATR) | 0.21 | 2.39 |
| MACD | -0.12 | -0.39 |
| Stochastic Oscillator | 8.04 | 11.12 |
Price Performance
Historical Comparison FOF
FBRX
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. The Fund's investment objective is to achieve total return, consisting of high current income and potential capital appreciation.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).